TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ENGN

enGene Holdings Inc.

Healthcare · Biotechnology

2.00$ +0.5% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

enGene Holdings Inc. (ENGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 221 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENGN
Line item 2020 2021 2022 2023 2024 2025
– 131 132 87 311 221
– 1.6 0.5 85 247 201
– 1.1 0.3 82 173 50
– 1.1 0.3 82 238 194
– 1.6 1.3 2.3 1.0 2.2
– 0.1 0.1 0.1 – –
– 4.1 4.6 14 39 54
– 0.3 0.9 5.3 15 32
– 1.0 1.3 0.6 1.1 10
– 1.0 0.7 1.2 1.4 6.7
– 3.0 31 9.2 22 15
– 127 127 72 273 168
– -2.3 -4.1 -200 -255 -372
16 16 16 24 45 51

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?